Discover 1,692 paid clinical trials in Colorado. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Colorado offers a variety of paid research opportunities, including paid studies for healthy volunteers and trials for those with specific health needs. Research hubs in Denver, Colorado Springs, and Boulder are actively recruiting participants, providing access to innovative treatments and exceptional medical care.
Filter
1
Filter results
Results: 1,692
FeaturedActive & Responsive
A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
for
Sleep Apnea, Obstructive, Obesity, Overweight
Location: Shreveport LA, Aurora CO
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT07369011
Phase 3, Recruiting
FeaturedActive & Responsive
Type 2 Diabetes Studies on Blood Sugar and Weight Management for Adults Not on Insulin
for
Diabetes Mellitus, Type 2, Obesity
Location: East Greenwich RI, Morehead City NC, Hampton VA,
Sex: All
Age: 18 - 70+
Recruiting
FeaturedActive & Responsive
Weight Loss Studies for Adults With a BMI of 27+, Including People Managing Type 2 Diabetes or Sleep Apnea
for
Obesity, Overweight, Diabetes Mellitus, Type 2,
Location: East Greenwich RI, Hampton VA, New Bern NC,
Sex: All
Age: 18+
Recruiting
FeaturedActive & Responsive
Diabetic Nerve Pain Study of a Non-Opioid Medication for Adults With Ongoing Foot and Leg Pain
for
Diabetic Neuropathies
Location: East Greenwich RI, East Syracuse NY, Washington DC,
Sex: All
Age: 18 - 70+
Recruiting
FeaturedActive & Responsive
Cardiovascular Disease Studies for Adults With High Blood Pressure, High Cholesterol, AFib, or Heart Failure
Location: Morehead City NC, Suffolk VA, New Bern NC, Annapolis MD,
Sex: All
Age: 18+
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
CRISPR-Edited Allogeneic Anti-BCMA CAR-T Cell Therapy in Patients With Relapsed/Refractory Multiple Myeloma
for
Relapsed/Refractory Multiple Myeloma
Location: New York NY, Hackensack NJ, Richmond VA, Durham NC,
Sponsor: Caribou Biosciences, Inc.
Sex: All
Age: 18+
Code: NCT05722418
Phase 1, Recruiting
Active & Responsive
LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
for
Ulcerative Colitis
Location: London, Boston MA, Providence RI, Trois-Rivieres,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18 - 70+
Code: NCT07186101
Phase 2, Recruiting
Active & Responsive
Risk Factors in Early Multiple Sclerosis
for
Multiple Sclerosis, Magnetic Resonance Imaging, Biomarkers,
Location: Aurora CO
Sponsor: University of Colorado, Denver
Sex: All
Age: 18 - 30
Code: NCT03586986
Recruiting
Active & Responsive
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
for
Breast Neoplasms
Location: Rimouski, Boston MA, Quebec, Stony Brook NY,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06312176
Phase 3, Recruiting
Active & Responsive
Threat Interpretation Bias as Cognitive Marker and Treatment Target in Pediatric Anxiety: R33 Phase
for
Anxiety Disorders
Location: Denver CO
Sponsor: University of Denver
Sex: All
Age: 10 - 17
Code: NCT07818876
Recruiting
Active & Responsive
A Phase 3 Randomized Clinical Trial to Investigate the Safety and Efficacy of Palopegteriparatide at Doses Greater Than 30 μg/Day in Adult Participants With Hypoparathyroidism
for
Hypoparathyroidism, Endocrine System Diseases,
Location: New York NY, New Brunswick NJ, Greenville NC,
Sponsor: Ascendis Pharma Bone Diseases A/S
Sex: All
Age: 18+
Code: NCT07081997
Phase 3, Recruiting
Active & Responsive
Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS
for
Amyotrophic Lateral Sclerosis
Location: Boston MA, New York NY, Montreal, Philadelphia PA,
Sponsor: Prilenia
Sex: All
Age: 18 - 70+
Code: NCT07322003
Phase 3, Recruiting
Active & Responsive
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
Location: Brewer ME, Scarborough ME, Peabody MA, Boston MA,
Sponsor: National Cancer Institute (NCI)
Sex: Female
Age: 18+
Code: NCT07198074
Phase 3, Recruiting
Active & Responsive
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
for
Intestinal Neoplasms, Gastrointestinal Neoplasms,
Location: Topsham ME, Westbrook ME, Boston MA, Newton MA,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT07222800
Phase 3, Recruiting
Active & Responsive
Data Collection Study Using CS (CardiacSense) BP (Blood Pressure) Watch and Pillow Systems
for
Blood Pressure Monitoring
Location: Louisville CO
Sponsor: CardiacSense Ltd.
Sex: All
Age: 50 - 70+
Code: NCT07749963
Recruiting
Active & Responsive
BIOTRONIK Investigation of the LivIQ Leadless Pacemaker System
for
Leadless Pacemaker, Bradycardia, AV Block,
Location: Boston MA, The Bronx NY, New York NY, Philadelphia PA,
Sponsor: Biotronik, Inc.
Sex: All
Age: 18+
Code: NCT07118358
Recruiting
Active & Responsive
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
for
Pancreatic Cancer, Pancreatic Cancer Metastatic, PDAC,
Location: New York NY, Belleville NJ, East Brunswick NJ,
Sponsor: Immuneering Corporation
Sex: All
Age: 18+
Code: NCT07562152
Phase 3, Recruiting
Active & Responsive
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
for
Alzheimer's Disease
Location: Halifax, East Providence RI, Newton MA, Quebec,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 60 - 70+
Code: NCT06976216
Phase 3, Recruiting
Active & Responsive
Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Differentiated Sarcomas
for
Metastatic Dedifferentiated Liposarcoma,
Location: Boston MA, Waterford CT, Guilford CT, New Haven CT,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06422806
Phase 3, Recruiting
Active & Responsive
Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial